Division of Molecular Medicine and Gene Therapy
21 – 30 of 618
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
- Contribution to journal › Article
-
Mark
Transcription factor-mediated reprogramming to antigen-presenting cells
- Contribution to journal › Scientific review
- 2024
-
Mark
Orchestrating an immune response to cancer with cellular reprogramming
- Contribution to journal › Letter
-
Mark
Reprogramming Stars #15 : Colliding Cellular Reprogramming Paths— An Interview with Dr. Stefan Stricker
- Contribution to journal › Debate/Note/Editorial
-
Mark
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance
- Contribution to journal › Article
-
Mark
Hematopoietic stem cell dynamics during regenerative stress
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Hematopoietic cells emerging from hemogenic endothelium exhibit lineage-specific oxidative stress responses
- Contribution to journal › Article
-
Mark
The Impact of Senescent Cells on Limb Regeneration
- Contribution to journal › Debate/Note/Editorial
-
Mark
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
- Contribution to journal › Article
-
Mark
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells
- Contribution to journal › Article
